Announcements Trials
Browse Landscape

Phase

Phase 1 18Phase 2 14Phase 3 4Phase 1/2 3Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 39NIH 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2CNS 1

Conditions

Breast Neoplasms 38Prostatic Neoplasms 18Lymphoma 17Precursor Cell Lymphoblastic Leukemia-Lymphoma 15Lung Neoplasms 15Carcinoma, Non-Small-Cell Lung 15Neoplasms 14Leukemia 13Rectal Neoplasms 12Uterine Cervical Neoplasms 10Unspecified Adult Solid Tumor, Protocol Specific 10Colorectal Neoplasms 10Colonic Neoplasms 10Sarcoma 9Leukemia, Myeloid, Acute 8Central Nervous System Neoplasms 8Brain Neoplasms 8Pain 7Ovarian Neoplasms 7Neuroblastoma 7Myelodysplastic Syndromes 7Leukemia, Lymphocytic, Chronic, B-Cell 7Head and Neck Neoplasms 7Small Cell Lung Carcinoma 6Multiple Myeloma 6Lymphoma, Non-Hodgkin 6Carcinoma, Ovarian Epithelial 6Burkitt Lymphoma 6Testicular Neoplasms 5Sezary Syndrome 5

Interventions

Zidovudine 2Methotrexate 2Leucovorin 2Dexamethasone 2Vincristine 1Doxorubicin 1Cytarabine 1Cyclophosphamide 1Bleomycin 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × NIH × Acquired Immunodeficiency Syndrome × Clear all
NCT00000703 2021-11-03

Chemotherapy and Azidothymidine, With or Without Radiotherapy, for High Grade Lymphoma in AIDS-Risk Group Members

National Institute of Allergy and Infectious Diseases (NIAID)

Phase NA Completed
45 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Lymphoma, Non-Hodgkin, HIV Infections

NCT00000723 2021-10-28

The Use of Chemotherapy Plus Radiotherapy Plus Azidothymidine in Patients With AIDS-Related Lymph Node Cancer

National Institute of Allergy and Infectious Diseases (NIAID)

Phase NA Terminated
45 enrolled
CNSLymphoid

Acquired Immunodeficiency Syndrome, Brain Neoplasms, Lymphoma, Lymphoma, Non-Hodgkin, HIV Infections, AIDS-Related Opportunistic Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡